Drug Trials Snapshot: WELIREG (belzutifan)

Drug Trials Snapshot: WELIREG WELIREG (belzutifan) WELIREG is a drug used for the treatment of adults with von Hippel-Lindau (VHL) disease who require therapy for associated renal cell carcinoma, central nervous system hemangioblastomas, or pancreatic neuroendocrine tumors, not requiring immediate surgery. VHL disease is a rare hereditary condition characterized by the formation of tumors and fluid-filled sacs (cysts) in many parts of the body. https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshot-welireg